- Target
- TBC1D23
- Reactivity
- Human,Mouse
- Application
- WB
- MW(Calculated)
- 77kD
- MW(Observed)
- --
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-2000
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from human TBC1D23
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of TBC1D23 at Human, Mouse
- Gene Name
- TBC1D23 NS4ATP1
- Protein Name
- TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1)
- Other Name
- --
- Organism-1
- Human
- Gene ID-1
- 55773
- SwissProt-1
- Q9NUY8
- Organism-2
- Mouse
- Gene ID-2
- 67581
- SwissProt-2
- Q8K0F1
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Golgi apparatus, trans-Golgi network . Cytoplasmic vesicle . Localization to the trans-Golgi is regulated by ARL1 and ARL5B/ARL8. ARL1 increases Golgi localization, while ARL5B decreases it. Recruitment to the trans-Golgi network requires the presence of GOLGA1 and GOLGA4, but not that of FAM91A1 (PubMed:29084197, PubMed:28823706). Recruited on AP-1-derived vesicles by WDR11 complex (PubMed:29426865). .